Literature DB >> 7633450

Characterization of FMR1 proteins isolated from different tissues.

C Verheij1, E de Graaff, C E Bakker, R Willemsen, P J Willems, N Meijer, H Galjaard, A J Reuser, B A Oostra, A T Hoogeveen.   

Abstract

FMR1 protein expression was studied in different tissues. In human, monkey and murine tissues, high molecular mass FMR1 proteins (67-80 kDa) are found, as shown in lymphoblastoid cells lines. The identity of these proteins was confirmed by their absence in tissues from patients with the fragile X syndrome and a FMR1 knock-out mouse. An Ile367Asn substitution in the FMR1 protein did not alter the translation, processing and localization of FMR1 proteins in lymphoblastoid cells from a patient carrying this mutation. All the high molecular mass FMR1 proteins isolated from normal lymphoblastoid cells and cells from the patient with the Ile367Asn substitution were able to bind RNA. However, the FMR1 proteins of the patient had reduced affinity for RNA binding at high salt concentrations. In some human, monkey and murine tissues low molecular mass FMR1 proteins (39-41 kDa) were found, which had the same N terminus as the 67-90 kDa isoforms, but differ in their C terminus and are therefore most likely the result of carboxy-terminal proteolytic cleavage. These low molecular mass FMR1 proteins did not bind RNA, in contrast with the high molecular mass FMR1 proteins. The significance of these low molecular mass proteins remains to be studied.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7633450     DOI: 10.1093/hmg/4.5.895

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  15 in total

1.  Subcellular localization of fragile X mental retardation protein with the I304N mutation in the RNA-binding domain in cultured hippocampal neurons.

Authors:  M Castrén; A Haapasalo; B A Oostra; E Castrén
Journal:  Cell Mol Neurobiol       Date:  2001-02       Impact factor: 5.046

Review 2.  The fragile X syndrome.

Authors:  A T Hoogeveen; B A Oostra
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

3.  Cellular distribution of the fragile X mental retardation protein in the mouse brain.

Authors:  Diego A R Zorio; Christine M Jackson; Yong Liu; Edwin W Rubel; Yuan Wang
Journal:  J Comp Neurol       Date:  2016-09-16       Impact factor: 3.215

4.  Prospects of TAT-mediated protein therapy for fragile X syndrome.

Authors:  Surya A Reis; Rob Willemsen; Leontine van Unen; Andre T Hoogeveen; Ben A Oostra
Journal:  J Mol Histol       Date:  2004-05       Impact factor: 2.611

5.  Oligomerization properties of fragile-X mental-retardation protein (FMRP) and the fragile-X-related proteins FXR1P and FXR2P.

Authors:  F Tamanini; L Van Unen; C Bakker; N Sacchi; H Galjaard; B A Oostra; A T Hoogeveen
Journal:  Biochem J       Date:  1999-11-01       Impact factor: 3.857

6.  Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them.

Authors:  M C Siomi; Y Zhang; H Siomi; G Dreyfuss
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

Review 7.  FMR1: a gene with three faces.

Authors:  Ben A Oostra; Rob Willemsen
Journal:  Biochim Biophys Acta       Date:  2009-02-21

Review 8.  The RNA-binding fragile-X mental retardation protein and its role beyond the brain.

Authors:  Cassandra Malecki; Brett D Hambly; Richmond W Jeremy; Elizabeth N Robertson
Journal:  Biophys Rev       Date:  2020-07-11

Review 9.  The fragile X syndrome.

Authors:  B B de Vries; D J Halley; B A Oostra; M F Niermeijer
Journal:  J Med Genet       Date:  1998-07       Impact factor: 6.318

10.  Discrimination of common and unique RNA-binding activities among Fragile X mental retardation protein paralogs.

Authors:  Jennifer C Darnell; Claire E Fraser; Olga Mostovetsky; Robert B Darnell
Journal:  Hum Mol Genet       Date:  2009-06-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.